$BKLLF / $CODE This transformative delivery system will initially seek approval through the FDA 505(b)(2) accelerated pathway provisions. https://stockhouse.com/news/press-releases/2020/04/23/codebase-investment-adds-oral-mucosal-patent-filing-expanding-transdermal